{"id":"NCT00295061","sponsor":"Grifols Therapeutics LLC","briefTitle":"Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults","officialTitle":"Multi-center, Randomized, Double-blind, Crossover Trial to Evaluate the Pharmacokinetic Comparability of Alpha-1 MP to Prolastin in Subjects With Alpha1-antitrypsin Deficiency.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-05","primaryCompletion":"2007-02","completion":"2007-02","firstPosted":"2006-02-22","resultsPosted":"2014-09-09","lastUpdate":"2014-09-09"},"enrollment":24,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Alpha 1-Antitrypsin Deficiency"],"interventions":[{"type":"DRUG","name":"Alpha-1 MP","otherNames":["Alpha-1 antitrypsin (AAT)","TAL6004"]},{"type":"DRUG","name":"alpha-1 proteinase inhibitor (human)","otherNames":["Alpha-1 antitrypsin (AAT)","BAY x 5747","BAY 10-5233","TAL-05-00007"]}],"arms":[{"label":"1 Alpha-1 MP","type":"EXPERIMENTAL"},{"label":"2 Prolastin","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this clinical study (ChAMP - Comparability pharmacokinetics of Alpha-1 Modified Process) is to compare the pharmacokinetic, safety and tolerability of Alpha-1 Proteinase Inhibitor (Human), modified process (Alpha-1 MP) and Prolastin in adult Alpha1-antitrypsin deficient patients. Patients will be infused intravenously with study drug on a weekly schedule for 24 weeks.","primaryOutcome":{"measure":"Alpha-1 MP vs. ProlastinÂ® of Area Under the Curve (AUC) From Day 0 to Day 7","timeFrame":"Day 0 to Day 7","effectByArm":[{"arm":"Alpha-1 MP","deltaMin":155.9,"sd":null},{"arm":"Prolastin","deltaMin":152.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":8,"countries":["United States"]},"refs":{"pmids":["20920295"],"seeAlso":["http://www.alphaone.org","http://www.alphanet.org"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":24},"commonTop":["Upper respiratory tract infection","Headache","Arthralgia"]}}